BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11146217)

  • 1. Evaluation of a rapid qualitative prostate specific antigen assay, the One Step PSA(TM) test.
    Dok An C; Yoshiki T; Lee G; Okada Y
    Cancer Lett; 2001 Jan; 162(2):135-9. PubMed ID: 11146217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a rapid quantitative determination method of PSA concentration with gold immunochromatographic strips.
    Wu CC; Lin HY; Wang CP; Lu LF; Yu TH; Hung WC; Houng JY; Chung FM; Lee YJ; Hu JJ
    BMC Urol; 2015 Nov; 15():109. PubMed ID: 26530738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of hyper sensitive PSA assay kits for determination on low range of prostate specific antigen in prostate cancer].
    Akimoto S; Akakura K; Ohki T; Shimazaki J; Kuriyama M; Kawada Y
    Nihon Hinyokika Gakkai Zasshi; 1995 Feb; 86(2):256-62. PubMed ID: 7534843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a rapid one-step PSA test for primary prostate cancer screening.
    Ashida S; Yamasaki I; Kawada C; Fukuhara H; Fukata S; Tamura K; Karashima T; Inoue K; Shuin T
    BMC Urol; 2021 Sep; 21(1):135. PubMed ID: 34579701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new modification of the Chiron ACS assay for total prostate-specific antigen achieves equimolar response characteristics and improves the detection of prostate cancer.
    Oberpenning F; Weining C; Brandt B; De Angelis G; Heinecke A; Hamm M; Stieber P; Hertle L; Schmid HP; Semjonow A
    Clin Chem Lab Med; 2003 Jan; 41(1):90-4. PubMed ID: 12636056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of improving the acceptance rateof early detection testing for prostate cancerwith a one-step test for prostate-specific antigen in whole blood.
    Berg W; Linder C; Eschholz G; Link S; Schubert J
    Urol Int; 1999; 63(2):102-6. PubMed ID: 10592497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
    Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
    Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a new, rapid, qualitative, one-step PSA Test for prostate cancer screening: the PSA RapidScreen test.
    Miano R; Mele GO; Germani S; Bove P; Sansalone S; Pugliese PF; Micali F
    Prostate Cancer Prostatic Dis; 2005; 8(3):219-23. PubMed ID: 15897915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
    Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
    Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K
    Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
    de La Taille A; Houlgatte A; Houdelette P; Berlizot P; Fournier R; Ricordel I
    Prog Urol; 1997 Jun; 7(3):455-63. PubMed ID: 9273075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basic and clinical evaluation of the new kit for detection of serum prostate specific antigen (PSA)].
    Akiyama A; Tochimoto M; Ito T; Tsujino S; Aizawa T; Namiki K; Miki M
    Kaku Igaku; 1992 Sep; 29(9):1151-8. PubMed ID: 1280697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of free type and complex type prostate-specific antigen (PSA): differences in immunorecognition by Delfia PSA, ACS-PSA and Eiken PA kits].
    Sumi S; Umeda H; Koga F; Yano M; Imai T; Hosoya Y; Honda M; Maeda S; Suzuki T; Yoshida K; Negishi T
    Hinyokika Kiyo; 1996 Apr; 42(4):279-84. PubMed ID: 8693960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
    Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H
    Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL.
    Babaian RJ; Fritsche H; Ayala A; Bhadkamkar V; Johnston DA; Naccarato W; Zhang Z
    Urology; 2000 Dec; 56(6):1000-6. PubMed ID: 11113747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma.
    Thakur V; Singh PP; Talwar M; Mukherjee U
    Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
    Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
    JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen.
    Luderer AA; Chen YT; Soriano TF; Kramp WJ; Carlson G; Cuny C; Sharp T; Smith W; Petteway J; Brawer MK
    Urology; 1995 Aug; 46(2):187-94. PubMed ID: 7542820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
    Kato M; Okada K
    Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
    Horninger W; Cheli CD; Babaian RJ; Fritsche HA; Lepor H; Taneja SS; Childs S; Stamey TA; Sokoll LJ; Chan DW; Brawer MK; Partin AW; Bartsch G
    Urology; 2002 Oct; 60(4 Suppl 1):31-5. PubMed ID: 12384160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.